Monica White
Nurse Practitioner · Longview, TXNPI 1235145558
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.8%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Myriad Genetic Laboratories, Inc. accounts for 67.7% of it on its own, with 33 other manufacturers making up the rest. Reporting peaked in 2022 at $7,476 and has fallen 69.6% since, to $2,274 in 2025. Among nurse practitioner clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 186 payments — averaging $120.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myriad Genetic Laboratories, Inc.$15K
- AbbVie$2K
- Daiichi Sankyo Inc.$2K
- Lilly USA, LLC$1K
- Takeda Pharmaceuticals U.S.A., Inc.$461
- GSK$318
- plus $2K from 28 others
Across 2 payments — averaging $47,854 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Astrazeneca UK Limited$96K
What the payments were for
- Consulting fees$11,82553%
- Speaking & faculty fees$3,45015%
- Travel & lodging$1,8268%
- Food & beverage$4,95122%
- Education$3482%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myriad Genetic Laboratories, Inc. | 64 | $15,174 |
| AbbVie | 14 | $1,763 |
| Daiichi Sankyo Inc. | 6 | $1,577 |
| Lilly USA, LLC | 7 | $1,104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $461 |
| GSK | 11 | $318 |
| Pfizer | 12 | $303 |
| AstraZeneca | 8 | $226 |
| Incyte Corporation | 4 | $223 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $174 |
| Novartis | 7 | $136 |
| E.r. Squibb & Sons, L.L.C. | 8 | $127 |
| Regeneron Healthcare Solutions, Inc. | 4 | $90 |
| Johnson & Johnson | 3 | $76 |
| AVEO Pharmaceuticals, Inc. | 3 | $71 |
| Bayer | 2 | $61 |
| Adaptive Biotechnologies Corporation | 2 | $58 |
| ADC Therapeutics America, Inc. | 1 | $51 |
| Astellas Pharma US Inc | 2 | $47 |
| Seagen Inc. | 1 | $45 |
| Sobi, Inc | 2 | $43 |
| Epizyme, Inc. | 2 | $33 |
| Ipsen Biopharmaceuticals, Inc | 1 | $33 |
| Geron Corporation | 1 | $26 |
| Merck | 1 | $24 |
| Servier Pharmaceuticals LLC | 1 | $21 |
| Karyopharm Therapeutics Inc. | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| Array Biopharma Inc | 1 | $19 |
| Morphosys, US Inc. | 1 | $18 |
| Bristol Myers Squibb | 1 | $16 |
| CSL Behring | 1 | $14 |
| Tempus AI, Inc | 1 | $14 |
| Blueprint Medicines Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- myRisk$11,233
- DATROWAY$1,494
- PreciseTumor$1,200
- BRACAnalysis$750
- myChoice CDx$555
- FRUZAQLA$125
- JEMPERLI$121
- Venclexta$112
- MONJUVI$111
- PADCEV$105
How this compares
$22,400 in reported general payments places this provider in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Chloride | 20 | $151 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Longview
- Melissa SuttonLongview$18K
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Corrie BerkSan Antonio$155K
- Samantha OnealDallas$133K
- Onna FeuchterSouthlake$108K
- Stephanie AgrellaRound Rock$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.